Corina Dutcus, MD from Eisai Inc provided a summary of the findings from a clinical trial evaluating the combination of…
Browsing: Kidney Cancer
CD70: How Does ALLO-316 Eliminate or Destroy Malignancies in the TRAVERSE Trial? Samer Srour, MB ChB, MS By Samer Srour,…
Belzutifan and other Novel Therapies in Genitourinary Oncology 2023 By Rana McKay, MD – University of California San Diego We’re…
CHECKMATE-914 Phase 3 Dr. Brian Rini, MD [2022] CHECKMATE-914 Trial The purpose of this study is to determine if the…
COSMIC-313 Phase 3 Kidney Cancer Trial [2022] COSMIC-313 Kidney Cancer Trial I’m going to talk today about COSMIC-313 ( Ipi/Nivo…
CHECKMATE-914 Phase 3 Kidney Cancer Trial [2022] CHECKMATE-914 Trial I’m going to talk to you today about CHECKMATE-914 clinical trial,…
Enfortumab Vedotin was tested in a randomized phase 3 trial in patients with metastatic urothelial cancer who had previously received…